Woodline Partners’s Axonics, Inc. Common Stock AXNX Stock Holding History

Woodline Partners’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-51,255	Closed	-$2.9M	–	848
2022 Q2	$2.9M	Buy	+51,255	New	+$2.81M	0.04%	375

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Woodline Partners's AXNX Position: Q3 2022 in Review

Woodline Partners sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2022, closing a stake of 51,255 shares — an estimated $2.9M sold.

Woodline Partners first reported a position in AXNX in Q2 2022 and held it in 1 quarter. The position peaked at $2.9M in Q2 2022. 230 funds tracked by Wall St. Rank hold AXNX as of Q3 2022.

Woodline Partners reported no remaining Axonics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Woodline Partners sold 51,255 Axonics, Inc. Common Stock shares in Q3 2022, an estimated $2.9M.
Woodline Partners first reported a position in Axonics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Woodline Partners's Axonics, Inc. Common Stock position peaked at $2.9M in Q2 2022.
230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2022.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.